UAE – CellSave Arabia, a leading provider of advanced stem cell solutions, and Bioscience Institute have jointly launched a first-of-its-kind regenerative medicine service in the United Arab Emirates.
The first-of-its-kind regenerative medicine service in the UAE aims to harness the large-scale manufacturing of umbilical cord tissue and placenta stem cells to deliver transformative healthcare solutions.
The joint statement: “The joint expertise of CellSave Arabia and Bioscience Institute ushers in a new era of healthcare, offering individuals tailored and effective solutions to enhance their overall well-being and quality of life.”
Moreover, CellSave Arabia and Bioscience Institute have already co-built a state-of-the-art Good Manufacturing Practice (GMP) facility designed to make stem cells for use in human clinical trials.
This state-of-the-art GMP-certified manufacturing facility manufactures, processes, and derives stem cell products, following the highest quality, ethical practice, and safety standards in line with regulatory guidelines.
“The GMP-certified production environment guarantees the quality and clinical readiness of the stem cells provided by CellSave Arabia and Bioscience Institute for transplantation,” the companies claimed.
CellSave Arabia and Bioscience Institute have extended their partnership to introduce innovative treatments for skin aging, hair loss, early menopause, erectile dysfunction, and body performance concerns, just to name a few.
Their extraordinary regenerative capabilities and ability to differentiate into various cell types make them ideal for promoting tissue repair and regeneration.
“This collaboration provides a remarkable opportunity to address age-related conditions, traumatic injuries, body performance issues, and challenging diseases that were previously difficult to manage,” the companies announced.
Through their co-established manufacturing facility, the two parties will accelerate the processing activities of umbilical cord tissue and placental stem cells, which hold immense promise in advancing medical treatments.
This joint effort to tap extraordinary potential in restoring health and vitality aligns with CellSave Arabia’s commitment to delivering safe and effective stem cell therapies.
Commenting on this deal, Giuseppe Mucci, Chief Executive Officer and Founder of Bioscience Institute, said: “At Bioscience Institute, our mission is to push the boundaries of scientific innovation and create a positive impact on global healthcare.”
Overall, CellSave Arabia and Bioscience Institute will continue working closely to enhance patient access to transformative treatments and therapies in the UAE and beyond.
The partnership will combine their assets and capabilities to restore the proper functioning of organs and tissues using stem cell transplantation.
It aligns with the two entities’ shared vision to accelerate the progress of regenerative medicine and provide accessible evidence-based and transformative solutions to patients in need.
For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.
